On the public citation graph

Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study

0 signed · 89 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/14651858.cd000031.pub4openalex-snapshot
Antidepressants for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd000031.pub5openalex-snapshot
Antidepressants for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd000146.pub4openalex-snapshot
Nicotine replacement therapy for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd000165.pub4openalex-snapshot
Physician advice for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd001007.pub2openalex-snapshot
Group behaviour therapy programmes for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd001007.pub3openalex-snapshot
Group behaviour therapy programmes for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd001292.pub2openalex-snapshot
Individual behavioural counselling for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd001292.pub3openalex-snapshot
Individual behavioural counselling for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd006103openalex-snapshot
Nicotine receptor partial agonists for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd006103.pub2openalex-snapshot
Nicotine receptor partial agonists for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd006103.pub7openalex-snapshot
Nicotine receptor partial agonists for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd008286.pub3openalex-snapshot
Combined pharmacotherapy and behavioural interventions for smoking cessation
inferredcites →https://doi.org/10.1002/14651858.cd011823.pub2openalex-snapshot
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
inferredcites →https://doi.org/10.1007/978-3-540-69248-5_2openalex-snapshot
Nicotine Chemistry, Metabolism, Kinetics and Biomarkers
inferredcites →https://doi.org/10.1007/s00213-011-2341-1openalex-snapshot
Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence
inferredcites →https://doi.org/10.1007/s10880-008-9136-5openalex-snapshot
Post-Traumatic Growth After a Myocardial Infarction: A Matter of Personality, Psychological Health, or Cognitive Coping?
inferredcites →https://doi.org/10.1007/s11481-016-9656-yopenalex-snapshot
Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio
inferredcites →https://doi.org/10.1007/s40263-015-0243-1openalex-snapshot
Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date
inferredcites →https://doi.org/10.1016/j.clpt.2004.02.011openalex-snapshot
Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity*1
inferredcites →https://doi.org/10.1016/j.clpt.2006.02.006openalex-snapshot
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation
inferredcites →https://doi.org/10.1016/j.clpt.2006.06.011openalex-snapshot
Determinants of the rate of nicotine metabolism and effects on smoking behavior
inferredcites →https://doi.org/10.1016/j.clpt.2006.08.011openalex-snapshot
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
inferredcites →https://doi.org/10.1016/j.drugalcdep.2015.11.017openalex-snapshot
Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers
inferredcites →https://doi.org/10.1016/j.jpba.2016.08.041openalex-snapshot
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting
inferredcites →https://doi.org/10.1016/j.pbb.2008.10.016openalex-snapshot
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study
inferredcites →https://doi.org/10.1016/s0022-3565(24)36947-2openalex-snapshot
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
inferredcites →https://doi.org/10.1016/s0090-9556(25)08453-3openalex-snapshot
Role of human cytochrome P4502A6 in C-oxidation of nicotine.
inferredcites →https://doi.org/10.1016/s0140-6736(16)30272-0openalex-snapshot
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
inferredcites →https://doi.org/10.1016/s2213-2600(14)70294-2openalex-snapshot
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
inferredcites →https://doi.org/10.1038/clpt.2008.57openalex-snapshot
Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion
inferredcites →https://doi.org/10.1038/clpt.2013.57openalex-snapshot
Biomarkers for Smoking Cessation
inferredcites →https://doi.org/10.1038/ng.573openalex-snapshot
Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior
inferredcites →https://doi.org/10.1038/s41598-017-17994-8openalex-snapshot
Characterising the nicotine metabolite ratio and its association with treatment choice: A cross sectional analysis of Stop Smoking Services in England
inferredcites →https://doi.org/10.1046/j.1360-0443.2003.00295.xopenalex-snapshot
A meta‐analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins
inferredcites →https://doi.org/10.1056/nejmsb1609216openalex-snapshot
Real-World Evidence — What Is It and What Can It Tell Us?
inferredcites →https://doi.org/10.1080/01677060802572887openalex-snapshot
Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes
inferredcites →https://doi.org/10.1093/jat/30.6.386openalex-snapshot
Within-Subject Variation of the Salivary 3HC/COT Ratio in Regular Daily Smokers: Prospects for Estimating CYP2A6 Enzyme Activity in Large-Scale Surveys of Nicotine Metabolic Rate
inferredcites →https://doi.org/10.1093/jnci/djr237openalex-snapshot
Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
inferredcites →https://doi.org/10.1093/ntr/ntp161openalex-snapshot
Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels: A round-robin study
inferredcites →https://doi.org/10.1093/ntr/nts272openalex-snapshot
Race, Gender, and Nicotine Metabolism in Adolescent Smokers
inferredcites →https://doi.org/10.1093/ntr/ntu342openalex-snapshot
The Nicotine Metabolite Ratio in Pregnancy Measured bytrans-3′-Hydroxycotinine to Cotinine Ratio: Characteristics and Relationship With Smoking Cessation: Table 1.
inferredcites →https://doi.org/10.1093/ntr/ntv031openalex-snapshot
Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers
inferredcites →https://doi.org/10.1093/ntr/ntv125openalex-snapshot
The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio
inferredcites →https://doi.org/10.1093/ntr/ntw258openalex-snapshot
Prevalence and Impact of Long-term Use of Nicotine Replacement Therapy in UK Stop-Smoking Services: Findings From the ELONS Study
inferredcites →https://doi.org/10.1093/ntr/ntx083openalex-snapshot
Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries
inferredcites →https://doi.org/10.1093/pubmed/fdp074openalex-snapshot
The effectiveness of NHS smoking cessation services: a systematic review
inferredcites →https://doi.org/10.1111/add.12285openalex-snapshot
The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers
inferredcites →https://doi.org/10.1111/add.12353openalex-snapshot
Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene ( CYP2A6 )
inferredcites →https://doi.org/10.1111/add.12390openalex-snapshot
Commentary on C hen et al. (2014): Another step on the road to clinical utility of pharmacogenetics for smoking cessation?
inferredcites →https://doi.org/10.1111/add.12429openalex-snapshot
‘Real-world’ effectiveness of smoking cessation treatments: a population study
inferredcites →https://doi.org/10.1111/add.14032openalex-snapshot
Genome‐wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences
inferredcites →https://doi.org/10.1111/add.14450openalex-snapshot
Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study
inferredcites →https://doi.org/10.1111/j.1360-0443.1989.tb03059.xopenalex-snapshot
Measuring the Heaviness of Smoking: using self‐reported time to the first cigarette of the day and number of cigarettes smoked per day
inferredcites →https://doi.org/10.1111/j.1360-0443.2004.00995.xopenalex-snapshot
Outcome criteria in smoking cessation trials: proposal for a common standard
inferredcites →https://doi.org/10.1111/j.1360-0443.2005.01027.xopenalex-snapshot
The English smoking treatment services: short‐term outcomes
inferredcites →https://doi.org/10.1111/j.1360-0443.2005.01028.xopenalex-snapshot
The English smoking treatment services: one‐year outcomes
inferredcites →https://doi.org/10.1111/j.1360-0443.2011.03565.xopenalex-snapshot
Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review
inferredcites →https://doi.org/10.1158/1055-9965.epi-08-0242openalex-snapshot
Stability of the Nicotine Metabolite Ratio inad Libitumand Reducing Smokers
inferredcites →https://doi.org/10.1158/1055-9965.epi-10-0674openalex-snapshot
Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level
inferredcites →https://doi.org/10.1158/1055-9965.epi-12-0236openalex-snapshot
Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers
inferredcites →https://doi.org/10.1158/1055-9965.epi-14-0427openalex-snapshot
Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers
inferredcites →https://doi.org/10.1158/1055-9965.epi-14-1381openalex-snapshot
Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation
inferredcites →https://doi.org/10.1159/000376585openalex-snapshot
The WHO-5 Well-Being Index: A Systematic Review of the Literature
inferredcites →https://doi.org/10.1371/journal.pgen.1005498openalex-snapshot
A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism
inferredcites →https://doi.org/10.2217/pme.11.60openalex-snapshot
Treatment for Tobacco Dependence: A Potential Application for Stratified Medicine?
inferredcites →https://doi.org/10.3310/hta19950openalex-snapshot
Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study
inferredcites →https://doi.org/10.3389/fpsyg.2014.00781openalex-snapshot
Using Bayes to get the most out of non-significant results
inferredcites →https://doi.org/10.5860/choice.27-3338openalex-snapshot
Applied logistic regression

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4632941openalex-extracted
Association between Nicotine Metabolite Ratio and Smoking Cessation Medications in Chinese Male Smokers - Results of the China National Tobacco Cessation Cohort Study
inferred← citeshttps://doi.org/10.1016/j.addicn.2023.100076openalex-snapshot
The use of biomarkers to guide precision treatment for tobacco use
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2026.113294openalex-snapshot
Role of nicotine metabolite ratio in pharmacological interventions on smoking cessation: A systematic review and meta-analyses of randomized controlled trials
inferred← citeshttps://doi.org/10.1037/pha0000252openalex-snapshot
Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers.
inferred← citeshttps://doi.org/10.1080/17425255.2021.1863948openalex-snapshot
Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism
inferred← citeshttps://doi.org/10.1080/17476348.2024.2429675openalex-snapshot
Is the nicotine metabolite ratio a useful tool to improve the effectiveness, safety, and adherence to quitting smoking? Systematic review of the literature and meta-analysis
inferred← citeshttps://doi.org/10.1093/ntr/ntaa022openalex-snapshot
Associations Between Nicotine Metabolite Ratio and Gender With Transitions in Cigarette Smoking Status and E-Cigarette Use: Findings Across Waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study
inferred← citeshttps://doi.org/10.1093/ntr/ntad079openalex-snapshot
Can Treatment Support Mitigate Nicotine Metabolism-Based Disparities in Smoking Abstinence? Secondary Analysis of the Helping HAND 4 Trial
inferred← citeshttps://doi.org/10.1101/2024.10.23.24315983openalex-snapshot
Nicotine metabolite ratio as an informed biomarker to optimize acupuncture for smoking cessation: randomised controlled trial
inferred← citeshttps://doi.org/10.1111/adb.12930openalex-snapshot
Acute effects of a very low nicotine content cigarette on laboratory smoking lapse: Impacts of nicotine metabolism and nicotine dependence
inferred← citeshttps://doi.org/10.1111/resp.14702openalex-snapshot
Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD
inferred← citeshttps://doi.org/10.1146/annurev-clinpsy-081219-090343openalex-snapshot
Smoking Treatment: A Report Card on Progress and Challenges
inferred← citeshttps://doi.org/10.1158/1940-6207.capr-19-0259openalex-snapshot
The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions
inferred← citeshttps://doi.org/10.1158/1940-6207.capr-24-0449openalex-snapshot
Nicotine Metabolite Ratio in People with HIV Who Smoke Cigarettes Receiving Pharmacologic and Behavioral Cessation Therapy
inferred← citeshttps://doi.org/10.11606/t.5.2020.tde-07072020-170623openalex-snapshot
Análise da associação dos perfis de expressão gênica e das concentrações de metabólitos com a resposta ao tratamento antitabagismo
inferred← citeshttps://doi.org/10.18332/tpc/217141openalex-snapshot
Nicotine metabolite ratio and attitude towards nicotine metabolite ratio informed smoking cessation care in Jordan
inferred← citeshttps://doi.org/10.3389/fphar.2022.900112openalex-snapshot
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
inferred← citeshttps://doi.org/10.3390/ijerph22071040openalex-snapshot
The Nicotine Metabolite Ratio and Response to Smoking Cessation Treatment Among People Living with HIV Who Smoke in South Africa
inferred← citeshttps://doi.org/10.3390/ijerph23091171openalex-snapshot
Using Conditional Random Forest and Feature Ranking Algorithms to Determine the Relative Importance of the Nicotine Metabolite Ratio (NMR) and Demographic and Behavioral Factors on Nicotine Dependence Severity
inferred← citeshttps://doi.org/10.3390/jox15020044openalex-snapshot
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation
showing the first 20 of 21 · page through all 21
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.